TECregen, a biotechnology company focused on thymus regeneration, has completed [...]

The biopharmaceutical industry is heading into 2026 with renewed but [...]

The Biotech Growth Trust has appointed Dame Jenny Harries as [...]

Enhanced Genomics has secured an additional funding round, bringing its [...]

James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.

Vivodyne has secured $40 million in Series A funding to [...]